Neuro-protective effects of carbamazepine on sleep patterns and head and body shakes in kainic acid-treated rats

Chemico-Biological Interactions

Volumn 180, Issue 3, 2009, Pages 376-382

  Alfaro Rodríguez, Alfonso ^a   González Piña, Rigoberto ^a   Arch Tirado, Emilio ^a   Carrasco Portugal, Miriam ^b   Pérez Guillé, Beatríz ^c   Soriano Rosales, Rosa Eugenia ^c   Padilla Martin, Krystell ^a   Uribe Escamilla, Rebeca ^a   Labra Ruiz, Norma ^c  

^a INSTITUTO NACIONAL DE REHABILITACIÓN   (Mexico)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^c INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

5 HT; Carbamazepine; Head and body shakes; Kainic acid; Rat; Sleep

Indexed keywords

CARBAMAZEPINE; KAINIC ACID; MONOAMINE;

5 HYDROXYINDOLEACETIC ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; BODY MOVEMENT; CONTROLLED STUDY; HEAD MOVEMENT; MALE; MESENCEPHALON; NEUROPROTECTION; NONHUMAN; PONS; RAT; REM SLEEP; SEIZURE; SEROTONIN BRAIN LEVEL; SLEEP PATTERN; SLOW WAVE SLEEP; WAKEFULNESS;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; CALCIUM CHANNELS, L-TYPE; CARBAMAZEPINE; KAINIC ACID; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; SEIZURES; SEROTONIN; SLEEP;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 67349248542     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.04.007     Document Type: Article

References (64)

1. 2+ channels in culture rat hippocampal neurons stimulated with glutamate receptor agonists. Neuropharmacology 38 (1999) 1349-1350
2. MacDonald R.L., and Kelly K.M. Antiepileptic drug mechanisms of action. Epilepsia 34 5 (1993) 51-58
3. Grabenstatter H.L., Clark S., and Dudet F.E. Anticonvulsivant effects of carbamazepine on spontaneous seizures in rats with kainate-induced epilepsy: comparison of intraperitoneal injections with drug-in-food protocols. Epilepsia 48 12 (1998) 2287-2295
4. Wang L., Zuo C.H., Zhao D.Y., and Wu X.R. Brain distribution and efficacy of carbamazepine in kainic acid induced seizure in rats. Brain Dev. 22 3 (1998) 154-157
5. Nabatame S., Okinaga T., Imai K., Kamio N., Kagitani-Shimono K., Nagai T., Kurosawa K., and Ozono K. Effect of carbamazepine on epilepsy with 1p36 deletion syndrome. No To Kattatsu 39 4 (1998) 289-294
6. Sun G.C., Werkman T.R., and Wadman W.J. Kinetic changes and modulation by carbamazepine on voltage-gated sodium channels in rat CA1 neurons after epilepsy. Acta Pharmacol. Sin. 12 (2006) 1537-1546
7. Galindo C., and Sitges M. Dihydropiridines mechanism of action in striatal isolated nerve endings. Comparison with-agotoxin IVA. Neurochem. Res. 29 (2004) 659-669
8. Sitges M., and Nekrassov V. Vimpocetine prevents 4-aminopyridine-induced changes in the EEG, auditory brainstem responses and hearing. Clin. Neurophysiol. 115 (2004) 2711-2717
9. + channel-mediated release. Neuropharmacology 53 (2007) 854-862
10. Schirrmacher K., Maye A., Walden J., Dusing R., and Bingmann D. Effects of carbamazepine on action potentials and calcium currents in rat spinal ganglion cell in vitro. Neurophychobiology 27 (1993) 176-179
11. Kuzmiski J.B., Barr W., Zamponi G.W., and MacVicar B.A. Topiramate inhibits the initiation of plateau potentials in CA 1 neurons by depressing R-type calcium channels. Epilepsia 46 (2005) 481-489
12. Turski L., Mejdrum B.S., Tursqui W.A., and Walkins J.C. Evidence that antagonist at non-NMDA receptors results in anticonvuslsant action. Eur. J. Pharmacol. 136 (1998) 69-73
13. Löscher W. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Prog. Neurobiol. 54 (1998) 721-741
14. Gigli G.L., Placidini F., Diomedi M., Maschio M., Silvestre G., Scalise A., and Marciani M.G. Nocturnal sleep and daytime somnolence in untreated patients with temporal lobe epilepsy: changes after treatment with controlled-release carbamazepine. Epilepsia 38 6 (1998) 676-701
15. Malow B., Selwa L., Ross D., and Aldrich M. Lateralizing value of interictal spikes on overnight sleep-EEG studies in temporal lobe epilepsy. Epilepsia 40 11 (1998) 1592-1597
16. Bazil C.W., and Walczak T.S. Effects of sleep and sleep stage on epileptic and nonepileptic seizures. Epilepsia 38 (1998) 69
17. Bazil C.W., Castro L.H., and Walczakt T.S. Reduction of rapid eye movement sleep by diurnal and nocturnal seizures in temporal lobe epilepsy. Arch. Neurol. 57 (2000) 363-368
18. Halász P. Sleep arousal and electroclinical manifestations of generalized epilepsy with spike wave pattern. In: Degen R., and Niedermeyer E. (Eds). Epilepsy, Sleep and Sleep Deprivation (1984), Elsevier, Amsterdam 97-107
19. Lothman E.W., and Collins R.C. Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res. 218 (1981) 299-318
20. Ben-Ari Y. Limbic seizure and damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience (1985) 375-403
21. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42 (1994) 1-32
22. Ben-Ari Y., Tremblay E., Riche D., Ghilini G., and Naquel R. Electroencephalographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculine or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 6 (1981) 1361-1391
23. Akaike K., Tanaka H., Tojo S., Fukumoto S., Imamura S., and Takigawa M. Kainic acid-induced dorsal and ventral hippocampal seizures in rats. Brain Res. 900 (2001) 65-71
24. Barcia J.A., Rubio P., Alos M., Serralta A., and Belda V. Anticonvulsivant and neurotoxic effects of intracerebroventricular injection of phenytoin, phenobarbital and carbamazepine in an amigdal-kindilng model of epilepsy in the rat. Epilepsy Res. 33 2-3 (1999) 159-167
25. Olfert E.D., Cross B.M., and Mc willian A.A. Guide for the Care and Use of Experimental Animals vol. 1 (1993), Canadian Council on Animal Care p. 211
26. Alfaro-Rodríguez A., and González-Piña R. Ozone-induced paradoxical sleep decrease is related to diminished acetylcholine levels in the medial preoptic area in rats. Chem.-Biol. Interact. 151 (2005) 151-158
27. Altagracia M.A., Monroy-Noyola L., Osorio-Rico L., Kravzov J., Alvarado-Calvillo R., Manjarrez J., and Rios C. Dapsone attenuates kainic acid-induced seizures in rats. Neurosci. Lett. 17 (1994) 652-654
28. Glowinsky J., and Iversen L.L. Regional studies of catecholamines in the rat brain. Disposition of 3H-norepinephrine, 3H-dopamine, and 3H-DOPA in varius regions of the brain. J. Neurochem. 13 (1966) 655-669
29. Alfaro-Rodríguez A., González-Piña R., González-Maciel A., and Arch-Tirado E. Serotonin and 5-hydroxy-indole-acetic acid contents in dorsal raphe and suprachiasmatic nuclei in normal, malnourished and rehabilitated rats under 24 h of sleep deprivation. Brain Res. 19 1110 (1) (2006) 95-101
30. McNamara J.O., and Shin C. Mechanism of epilepsy. Annu. Rev. Med. 45 (1994) 379-389
31. Sammaritano M., and Sherwin A. Effect of anticonvulsants on sleep. Neurology 54 5 Suppl. 1 (2000) S16-S24
32. Roberts R. Differential diagnosis of sleep disorders, non-epileptic attacks and epileptic seizures. Curr. Opin. Neurol. 11 (1998) 135-139
33. Crespel A., Coubes P., and Baldy-Molulinier M. Sleep influence on seizures and epilepsy effects on sleep in partial frontal and temporal lobe epilepsies. Clin. Neurophysiol. 111 Suppl. 2 (2000) S54-S59
34. Schliebs R., Zivin M., Steinbach J., and Rothe T. Changes in cholinergic but not in GABAergic markers in amygdala, piriform cortex and nucleus basalis of the rat brain following systemic administration of kainic acid. J. Neurochem. 53 (1989) 212-218
35. Sloviter R.S., and Damiano B.P. Sustained electrical stimulation of the perforant path duplicates kainate induced electrophysiologic effects and hippocampal damage in rats. Neurosci. Lett. 24 (1981) 229-284
36. Degen R., and Rodin E.A. Epilepsy, Sleep and Sleep Deprivation (1991), Elsevier, Amsterdam
37. Frank M.G., Page J., and Helle H.C. The effects of REM sleep-inhibiting drugs in neonatal rats: evidence for a distinction between neonatal active sleep and REM sleep. Brain Res. 778 (1997) 64-72
38. Placidi F., Marciani M.G., Diomedi M., Sauri F., Giacomini P., and Gigli G.L. Effects of Lamotrogine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy. Acta Neurol. Sacnd. 102 (2000) 81-86
39. Lerma J., Paternain A.V., Rodríguez-Moreno A., and Lopez Garcia J.C. Molecular physiology of Kainate receptors. Physiol. Rev. 81 (2001) 971-978
40. Min M.Y., Meyland Z., and Kullmann D.M. Synaptically released glutamate reduces gamma-aminobutyric acid (GABA)ergic inhibition in the hippocampus via kainate receptors. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 9932-9937
41. Alfaro-Rodríguez A., Labra-Ruíz N., Carrasco-Portugal M., González-Maciel A., Pérez-Guille B., Soriano-Rosales R., et al. Effect of carbamazepine on sleep patterns disturbed by epilepsy. Proc. West. Pharmacol. Soc. 45 (2002) 62-64
42. Ayala-Guerrero F., Alfaro-Rodríguez A., Martínez C., Campos-Sepúlveda E., Vargas L., and Mexicano G. Effect of kainic acid-induced seizures on sleep patterns. Proc. West. Pharmacol. Soc. 45 (2002) 178-180
43. Bedard P., and Pycock C.J. Wet-dog shakes behavior in the rat: a possible quantitative model of central 5-hydroxytryptamine activity. Neuropharmacology 16 (1977) 663-670
44. Stewart R.M., Growdon J.H., Cancian D., and Baldessarini R.J. 5-hydroxitryptophan-induced myoclonus: increased sensitivity to serotonin after intracranial 5,7-dihydroxytryptamine in the adult rat. Neuropharmacology 15 (1976) 449-455
45. Kalia M. Neurobiology of sleep. Metabolism 55 10 Suppl. 2 (2006) S2-S6
46. Monti J.M., and Jantos H. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. Prog. Brain Res. 172 (2008) 625-646
47. Shouse M.M., and Siegel J.M. Pontine regulation of REM sleep components in cats: integrity of the pedunculopontine tegmentum (PPT) is important for phasic events but unnecessary for attonia during REM sleep. Brain Res. 571 (1992) 50-63
48. Hobson J.A., and Schmajuk N.A. Brain state and plasticity: an integration of the reciprocal interaction model of sleep cycle oscillation with attentional models of hippocampal function. Arch. Ital. Biol. 126 4 (1988) 209-224
49. Hobson J.A., McCarley R.W., and Wyzinski P.W. Sleep cycle oscillation reciprocal discharge by two brain neuronal groups. Science 189 (1975) 55-58
50. Koyama Y., and Kayama Y. Mutual interactions among cholinergic, noradrenergic and serotonergic neurons studied by ionophoresis of these transmitters in rat brainstem nuclei. Neuroscience 55 (1993) 117-1126
51. Douglas C.L., Demarco G.J., Baghdoyan H.A., and Lydic R. Pontine and basal forebrain cholinergic interaction: implications for sleep and breathing. Respir. Physiol. Neurobiol. 15 143 (2-3) (2004) 251-262
52. Gao J., Zhang J.X., and Xu T.I. Modulation of serotonergic projection from dorsal raphe nucleus to basolateral amygdale on sleep-waking cycle of rats. Brain Res. 26 945 (1) (2002) 60-70
53. Heggli D.E., Almodt A., and Malthe-Sorenssen D. Kainic acid neurotoxity; effect of systemic injection on neurotransmitter markers in different brain regions. Brain Res. 230 (1981) 253-262
54. Anderson K., Schwartz R., and Fuxe K. Compensatory bilateral changes in dopamine turnover alter striatal kainate lesion. Nature 283 (1980) 94-96
55. Osorio-Rico L., Mancera-Flores M., and Rios C. Changes in brain serotonin turnover, body and head shakes in kainic acid-treated rats. Pharmacol. Toxicol. 92 (2003) 143-147
56. Ohta K., Araki N., Shibata M., Komatsumoto S., Shimazu K., and Fukuuchi Y. Presynaptic ionotropic glutamate receptors modulate in vivo release and metabolism of striatal dopamine, noradrenaline, and 5-hydroxytryptamine: involvement of both NMDA and AMPA/kainate subtypes. Neurosci. Res. 21 1 (1994) 83-89
57. Byrska B., Reichenberg K., Romansika I., and Vetulani J. Behavioral and biochemical effects of intraventricular kainic acid. Pol. J. Pharmacol. Pharm. 32 (1990) 531-538
58. Sudha S., Lakshmana M.K., and Pradhan N. Changes in learning and memory, acetylcholinesterase activity and monoamines in brain after chronic carbamazepine administration in rats. Epilepsia 36 4 (1995) 416-422
59. Baf M.H., Subhash M.N., Lakshmana K.M., and Rao B.S. Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine. Neurochem. Res. 19 9 (1994) 1139-1143
60. 2+ levels in neuronal culture. Eur. J. Pharmacol. 14 219 (1) (1992) 53-57
61. Murphy S.N., and Miller R.J. Regulation of Ca2+ influx into striatal neurons by kainic acid. J. Pharmacol. Exp. Ther. 249 2 (1989) 184-193
62. Schumacher T.B., Beck H., Steinhäuser C., Schramm J., and Elger C.E. Effects of phenytoin, carbamazepine, and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy. Epilepsia 39 April (4) (1998) 355-363
63. Kitano Y., Komiyama C., Makino M., Satoh H., et al. Anticonvulsivant and neuro-protective effects of the novel nootropic agent nefiracetam on kainic acid-induced seizures in rats. Brain Res. 1057 1-2 (2005) 168-176
64. Uribe-Escamilla R., Mota-Rojas D., Sánchez-Aparicio P., Alonso-Spilsbury M., González-Piña R., and Alfaro-Rodríguez A. Effect of pentobarbital on pH and electrolyte levels after induced seizure in rats. Seizure 16 5 (2007) 397-401